Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0607-2018Class II

Synvisc-One (hylan G-F 20), 6mL delivered from a 10mL syringe

Sanofi Genzyme Corp. / initiated 2017-12-11 / Terminated / root cause: manufacturing process

Sanofi Genzyme began a recall of Synvisc-One (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B... on . FDA classified it as Class II and gives the reason as "Contamination with Methylbacterium thiocyanatum". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0607-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Sanofi Genzyme Corp.
Product
Synvisc-One (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
Product code
MOZ Acid, Hyaluronic, Intraarticular
Reason for recall
Contamination with Methylbacterium thiocyanatum
Root cause tag
manufacturing process
FDA root cause
Environmental control
Action
On December 11, 2017 Sanofi Genzyme distributed URGENT VOLUNTARY DEVICE RECALL notices and reply cards to their customers via courier service. Customers were advised to inspect inventory, immediately discontinue use and return all affected product. On December 19, 2017 Sanofi Genzyme distributed a 2nd notice titled DEVICE RECALL UPDATE NOTICE (2 of 3) notifying customers that the isolated bacterial organism was Methylbacterium thiocyanatum. On December 22, 2017 Sanofi Genzyme distributed a 3rd notice titled DEVICE RECALL UPDATE NOTICE (3 of 3) which included antibiotic sensitivity analysis guidance for the isolated organism. Customers who wish to return product should contact GENCO Pharmaceutical Services at 1-855-838-5782 for a recalled product return kit. Customers are encouraged to complete and return the Business Reply Card via fax to 1-414-459-8791 or via email to [email protected]. Sanofi Genzyme will issue you a credit or replacement product upon receipt of the recalled product by GENCO. All questions of a medical or clinical nature should be directed to Sanofi Medical Information Services in the U.S. at 1-800-633-1610, option 1. Sanofi US Customer service can be reached at 1-800-633-1610 option 7 then 4.
Quantity in commerce
12,380 units
Distribution
US Nationwide distribution(36 states)
Product codes and lots
Lot Number: 7RSL021 Expiration Date: 2020-05-31

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0607-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0607-2018Class IITerminatedVoluntary: Firm initiated